Cargando…
Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
Autores principales: | Wilson, Heather, Pagano, Gennaro, Yousaf, Tayyabah, Polychronis, Sotirios, De Micco, Rosa, Giordano, Beniamino, Niccolini, Flavia, Politis, Marios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468085/ https://www.ncbi.nlm.nih.gov/pubmed/35230538 http://dx.doi.org/10.1007/s00702-022-02476-7 |
Ejemplares similares
-
Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
por: Wilson, Heather, et al.
Publicado: (2019) -
Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
por: Yousaf, Tayyabah, et al.
Publicado: (2019) -
Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naïve Parkinson’s patients
por: Polychronis, Sotirios, et al.
Publicado: (2019) -
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Pagano, Gennaro, et al.
Publicado: (2017) -
Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson’s disease
por: Niccolini, Flavia, et al.
Publicado: (2019)